Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -15.98%-144.4M | ---- | 24.39%-124.5M | ---- | -170.25%-164.67M | ---- | -90.07%-60.93M | ---- | -313.60%-32.06M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 66.36%-110K | ---- | -65.15%-327K | ---- | -43.48%-198K | ---- | -55.06%-138K | ---- | 86.14%-89K |
| Attributable subsidiary (profit) loss | ---- | --70K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | -96.90%89K | ---- | -70.59%2.87M | ---- | 3,423.83%9.76M | ---- | -96.81%277K | ---- | --8.7M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | --6.74M | ---- | ---- | ---- | --3.11M |
| -Impairment of trade receivables (reversal) | ---- | -96.90%89K | ---- | 63.51%2.87M | ---- | 630.83%1.75M | ---- | -52.66%240K | ---- | --507K |
| -Other impairments and provisions | ---- | ---- | ---- | -99.76%3K | ---- | 3,318.92%1.27M | ---- | -99.27%37K | ---- | --5.08M |
| Revaluation surplus: | ---- | --6.72M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Derivative financial instruments fair value (increase) | ---- | --6.72M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | 99.99%-4K | ---- | ---28.6M | ---- | ---- | ---- | -98.87%15K | ---- | 33,050.00%1.33M |
| -Loss (gain) from sale of subsidiary company | ---- | 99.99%-4K | ---- | ---28.6M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.87%15K | ---- | 33,050.00%1.33M |
| Depreciation and amortization: | ---- | -5.14%16.04M | ---- | -23.41%16.91M | ---- | 29.74%22.08M | ---- | 28.20%17.02M | ---- | 60.38%13.28M |
| -Amortization of intangible assets | ---- | 33.54%4.05M | ---- | 42.21%3.03M | ---- | 86.19%2.13M | ---- | 159.41%1.14M | ---- | --441K |
| Financial expense | ---- | 188.13%14.18M | ---- | 14.17%4.92M | ---- | 253.07%4.31M | ---- | 7.58%1.22M | ---- | 432.86%1.14M |
| Special items | ---- | -18.86%62.97M | ---- | 2.93%77.61M | ---- | 792.35%75.4M | ---- | --8.45M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 13.05%-44.45M | ---- | 4.13%-51.12M | ---- | -56.41%-53.32M | ---- | -341.85%-34.09M | ---- | -7,663.73%-7.72M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -2,950.00%-61K | ---- | 99.13%-2K | ---- | 94.03%-229K | ---- | -124.81%-3.83M | ---- | -655.37%-1.71M |
| Accounts receivable (increase)decrease | ---- | 53.55%-17.25M | ---- | -646.16%-37.13M | ---- | 51.55%-4.98M | ---- | -268.69%-10.27M | ---- | 50.81%6.09M |
| Accounts payable increase (decrease) | ---- | 240.32%22.43M | ---- | -74.70%6.59M | ---- | 243.70%26.06M | ---- | -1,400.99%-18.13M | ---- | 40.29%-1.21M |
| Special items for working capital changes | ---- | 106.89%946K | ---- | -8,996.03%-13.74M | ---- | -119.76%-151K | ---- | 236.92%764K | ---- | 60.26%-558K |
| Cash from business operations | ---- | 59.77%-38.37M | ---- | -192.44%-95.39M | ---- | 50.25%-32.62M | ---- | -1,185.99%-65.56M | ---- | -600.29%-5.1M |
| Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --889K | ---- | ---- |
| Interest received - operating | ---- | -65.22%72K | ---- | 10,250.00%207K | ---- | -66.67%2K | ---- | 200.00%6K | ---- | -99.69%2K |
| Special items of business | 73.94%-2.01M | ---- | 87.41%-7.71M | ---- | -49.41%-61.26M | ---- | -73.56%-41M | ---- | ---23.62M | ---- |
| Net cash from operations | 73.94%-2.01M | 59.76%-38.3M | 87.41%-7.71M | -191.83%-95.19M | -49.41%-61.26M | 49.56%-32.62M | -73.56%-41M | -1,168.94%-64.67M | ---23.62M | -1,133.90%-5.1M |
| Cash flow from investment activities | ||||||||||
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---616K | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1K | --2.32M |
| Purchase of fixed assets | 52.40%-10.97M | -31.47%-38.21M | -113.92%-23.04M | -12.68%-29.06M | -68.79%-10.77M | -1,004.07%-25.79M | -490.38%-6.38M | 64.55%-2.34M | ---1.08M | -768.12%-6.59M |
| Purchase of intangible assets | -80.54%-2.61M | 7.30%-7.42M | 55.96%-1.44M | -20.97%-8M | ---3.28M | 13.78%-6.61M | ---- | -177.03%-7.67M | ---3.82M | ---2.77M |
| Sale of subsidiaries | ---- | 99.76%-4K | ---- | -396.13%-1.67M | ---- | ---336K | ---336K | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---13.93M |
| Cash on investment | ---- | ---75.6M | ---- | ---- | ---- | 99.48%-20K | ---- | ---3.84M | ---- | ---- |
| Net cash from investment operations | 44.56%-13.58M | -208.11%-121.23M | -74.27%-24.49M | -20.10%-39.35M | -109.15%-14.05M | -136.54%-32.76M | -37.16%-6.72M | 33.97%-13.85M | ---4.9M | -2,663.64%-20.98M |
| Net cash before financing | 51.60%-15.59M | -18.58%-159.53M | 57.24%-32.2M | -105.77%-134.53M | -57.83%-75.31M | 16.73%-65.38M | -67.31%-47.72M | -201.15%-78.52M | ---28.52M | -2,124.57%-26.07M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -19.11%53.1M | ---- | 116.13%65.64M | 50.54%6.17M | 8.09%30.37M | --4.1M | --28.1M | ---- | ---- |
| Refund | ---- | ---- | ---- | -9,491.55%-6.81M | ---- | 64.50%-71K | 33.00%-67K | 38.27%-200K | ---100K | 90.91%-324K |
| Issuing shares | ---- | 32.87%132.46M | -76.71%16M | 116.42%99.7M | 54.14%68.7M | -12.52%46.07M | 60.02%44.57M | 165.29%52.66M | --27.85M | -69.92%19.85M |
| Interest paid - financing | -93.36%-4.98M | -219.41%-10.4M | -459.78%-2.58M | 22.79%-3.26M | 64.64%-460K | -245.37%-4.22M | -130.67%-1.3M | -18.43%-1.22M | ---564K | -384.04%-1.03M |
| Issuance expenses and redemption of securities expenses | ---- | 31.51%-50K | ---- | 94.03%-73K | 76.47%-400K | 78.16%-1.22M | 69.95%-1.7M | ---5.6M | ---5.66M | ---- |
| Other items of the financing business | ---- | --16.01M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -157.01%-6.78M | 27.82%188.4M | -82.77%11.89M | 148.64%147.39M | 66.32%69M | -4.29%59.28M | 175.54%41.49M | 489.21%61.93M | --15.06M | -80.14%10.51M |
| Net Cash | -10.10%-22.36M | 124.52%28.87M | -222.09%-20.31M | 310.80%12.86M | -1.25%-6.31M | 63.22%-6.1M | 53.74%-6.23M | -6.57%-16.58M | ---13.46M | -130.07%-15.56M |
| Begining period cash | 123.48%52.25M | 122.21%23.38M | 122.21%23.38M | -36.70%10.52M | -36.70%10.52M | -49.94%16.62M | -49.94%16.62M | -31.91%33.21M | --33.21M | 368.77%48.77M |
| Cash at the end | 873.58%29.89M | 123.48%52.25M | -27.18%3.07M | 122.21%23.38M | -59.44%4.22M | -36.70%10.52M | -47.35%10.39M | -49.94%16.62M | --19.74M | -46.57%33.21M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Debo Certified Public Accountants Limited | -- | Debo Certified Public Accountants Limited | -- | Debo Certified Public Accountants Limited | -- | Debo Certified Public Accountants Limited | -- | Debo Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.